Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
7.42
+0.04 (0.54%)
At close: Jun 27, 2025, 4:00 PM
7.44
+0.02 (0.27%)
After-hours: Jun 27, 2025, 6:08 PM EDT

Gyre Therapeutics Statistics

Total Valuation

GYRE has a market cap or net worth of $672.67 million. The enterprise value is $644.37 million.

Market Cap 672.67M
Enterprise Value 644.37M

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025, before market open.

Earnings Date Aug 12, 2025
Ex-Dividend Date n/a

Share Statistics

GYRE has 90.66 million shares outstanding. The number of shares has increased by 44.36% in one year.

Current Share Class 90.66M
Shares Outstanding 90.66M
Shares Change (YoY) +44.36%
Shares Change (QoQ) +18.64%
Owned by Insiders (%) 7.02%
Owned by Institutions (%) 2.90%
Float 20.29M

Valuation Ratios

The trailing PE ratio is 92.77.

PE Ratio 92.77
Forward PE n/a
PS Ratio 7.11
Forward PS 6.72
PB Ratio 10.72
P/TBV Ratio 10.67
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 88.87
EV / Sales 6.40
EV / EBITDA 53.08
EV / EBIT 61.77
EV / FCF n/a

Financial Position

The company has a current ratio of 3.60, with a Debt / Equity ratio of 0.02.

Current Ratio 3.60
Quick Ratio 2.65
Debt / Equity 0.02
Debt / EBITDA 0.12
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is 12.12% and return on invested capital (ROIC) is 6.69%.

Return on Equity (ROE) 12.12%
Return on Assets (ROA) 5.18%
Return on Invested Capital (ROIC) 6.69%
Return on Capital Employed (ROCE) 9.41%
Revenue Per Employee $173,822
Profits Per Employee $12,523
Employee Count 579
Asset Turnover 0.80
Inventory Turnover 0.59

Taxes

In the past 12 months, GYRE has paid $3.68 million in taxes.

Income Tax 3.68M
Effective Tax Rate 23.91%

Stock Price Statistics

The stock price has decreased by -20.73% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -20.73%
50-Day Moving Average 9.06
200-Day Moving Average 11.07
Relative Strength Index (RSI) 39.41
Average Volume (20 Days) 258,802

Short Selling Information

The latest short interest is 1.41 million, so 1.56% of the outstanding shares have been sold short.

Short Interest 1.41M
Short Previous Month 1.42M
Short % of Shares Out 1.56%
Short % of Float 6.95%
Short Ratio (days to cover) 3.85

Income Statement

In the last 12 months, GYRE had revenue of $100.64 million and earned $7.25 million in profits. Earnings per share was $0.02.

Revenue 100.64M
Gross Profit 96.84M
Operating Income 10.43M
Pretax Income -74.61M
Net Income 7.25M
EBITDA 12.14M
EBIT 10.43M
Earnings Per Share (EPS) $0.02
Full Income Statement

Balance Sheet

The company has $29.89 million in cash and $1.59 million in debt, giving a net cash position of $28.31 million or $0.31 per share.

Cash & Cash Equivalents 29.89M
Total Debt 1.59M
Net Cash 28.31M
Net Cash Per Share $0.31
Equity (Book Value) 104.30M
Book Value Per Share 0.78
Working Capital 49.46M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$6.65 million and capital expenditures -$2.21 million, giving a free cash flow of -$8.86 million.

Operating Cash Flow -6.65M
Capital Expenditures -2.21M
Free Cash Flow -8.86M
FCF Per Share -$0.10
Full Cash Flow Statement

Margins

Gross margin is 96.23%, with operating and profit margins of 10.36% and 7.20%.

Gross Margin 96.23%
Operating Margin 10.36%
Pretax Margin 15.27%
Profit Margin 7.20%
EBITDA Margin 12.06%
EBIT Margin 10.36%
FCF Margin n/a

Dividends & Yields

GYRE does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -44.36%
Shareholder Yield -44.36%
Earnings Yield 1.08%
FCF Yield -1.32%
Dividend Details

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

GYRE has an Altman Z-Score of 26.76 and a Piotroski F-Score of 4.

Altman Z-Score 26.76
Piotroski F-Score 4